About Us

+Our Vision
XCyton's vision is to become the global leader in Diagnostic Product development and to put India on the world map of Medical diagnostics.
+Our Mission
  • Is to save lives and prevent disabilities.
  • To translate our passion for science and availability of cutting edge technology into product that will meet the unmet Medical Needs in patient care.
+Our Commitment
XCyton creates leaders; not managers.

  • Our motto at XCyton is to save lives and prevent disabilities thus improving the quality of life of an individual and the nation. We do this through innovations in medical science to meet the unmet medical needs.
  • XCyton is committed to creating an ambient atmosphere in which all employees can work together in a clean and safe environment. They can learn and build career in science.
  • Team XCyton is committed to provide delight to the customers and others who interact with the company.
Core Values:
The core values that are practised in XCyton are:
  • Integrity
  • Excellence
  • Responsibility
  • Team spirit/unity
+Accolades & Awards
  • Bio-Singapore Award - The Most Important Technology Developed in Asia in year 2009
  • Best Bio-Product Award - Syndrome Evaluation System by
    Biospectrum for the year 2008
  • Best Bio-Product Award - JEV-CheX by Biospectrum for the year 2004
  • Bio-Singapore Award - RABOBANK India Bio Business award for HIV CheX & HEP CheX C

Related Links


Molecular Diagnostic Services
Syndrome Evaluation System (SES)- A patented technology that comprises of rapid multiplex amplification and accurate identification of the virulence associated genes of the causative agents or organisms. This amazingly fast and accurate platform transcends all conventional diagnostic tests and helpful when organisms are difficult to cultivate or difficult to find. The accurate and rapid identification of the causative agents (7 hours of process time) empowers the clinician to initiate targeted therapy and thus save lives and significantly reduce disabilities such as blindness, paralysis, compromised mental faculties.

The technologies currently available for diagnosis of infections are grossly inadequate to detect early during the illness and institute specific therapy in critical illnesses resulting in loss of function or even loss of life.

The XCyton Advantage
  • Rapid: Process time of 7 hours
  • Higher Accuracy: detects more number of cases than conventional methods if conventional method detects 10-15% SES can give you a detection of 75%
  • Cost effectives: Avoids multiple testing and unnecessary investigations and reduces ICU stay
  • Provides Direct evidence for the presence of infection - detects DNA of pathogens
  • Comprehensive: Detects fungi, viruses, parasites and bacteria in a single test. It also detects uni-microbial or poly-microbial infections
  • Rules in or Rules out infections
  • Helps Clinician Save lives and Prevent Disabilities
The technology

The technology involves isolation of the genetic material of the causative agent from the given specimen and simultaneous amplification of the "Syndrome Specific Signature genes" of all the probable causative agents, followed by "Syndrome Specific Hybridization".

The amplification of the gene allows for higher sensitivity of the test and the re-naturation of the amplified signature gene to its chemically identified complementary gene sequence on the SES allows for higher specificity of the test. And the simultaneous detection of multiple pathogens allows for early diagnosis of the infection and initiation of therapy. XCyton offers SES as Molecular Diagnostic Services for various critical illnesses in three verticals - Eye Infections, Brain Infections and Sepsis or Blood stream infections.